Biopharmaceutical Competitiveness & Investment Report 2025
The latest BCI Report assessing the competitiveness of biopharmaceutical R&D investment environments, covering policy frameworks, market conditions, and innovation indicators across key economies.
Congressional Innovation Scorecard – Edition 2
The second edition of the Congressional Innovation Scorecard, evaluating U.S. legislators' voting records and policy positions on intellectual property and innovation.
Building the Bioeconomy (6th Edition)
The sixth edition covers 44 countries, examining pro-innovation policy frameworks and their correlation with biotechnology outputs across 28 indicators.
Building the Bioeconomy (5th Edition)
Examining national biotech policy frameworks across 33 countries, with analysis of how regulatory and IP environments drive biotechnology investment.
Building the Bioeconomy (4th Edition)
Quantifying the impact of policy on biotechnology innovation across leading markets. Includes full statistical annex.
Building the Bioeconomy: Race for Biopharmaceutical Innovation (3rd Edition)
Assessing the global race for biopharmaceutical innovation leadership and the policy frameworks driving competitive advantage.
Building the Bioeconomy: Measuring the Biomedical Pulse (2nd Edition)
Measuring the biomedical pulse of leading economies with a comprehensive set of indicators spanning policy inputs and biotechnology outputs.
Building the Bioeconomy (1st Edition)
The inaugural edition examining national biotechnology industry development strategies, policies, and best practices across major economies.
Scaling Up Global Clinical Trial Activity
A comprehensive analysis of global clinical trial activity, identifying the policy and regulatory factors that shape where clinical research is conducted.
EMA Regulatory Study
Analysis of the European Medicines Agency regulatory environment and its implications for pharmaceutical innovation and market access in Europe.
Generic Drugs: Appraisal and Approval
Assessment of generic drug appraisal and approval processes in the US market, examining regulatory efficiency and its impact on market competition.
Unlocking Global Health
Examining the policy and regulatory levers that determine access to medicines across healthcare systems, with a focus on IP, pricing, and market structure.
Patient Power
Analysis of patient-centred market access frameworks, examining how health systems can better align access policies with patient outcomes and needs.
Unintended Consequences
An in-depth examination of the unintended consequences of market access and pricing policies in biopharmaceutical markets across key economies.
AI Readiness in the Pharmaceutical Industry
A comprehensive assessment of AI adoption readiness across pharmaceutical sectors, covering regulatory frameworks, data infrastructure, and strategic positioning.
Innovative Futures
Exploring the innovation landscape and the strategic choices facing firms and policymakers in knowledge-intensive sectors over the coming decade.
The Next Frontier
Identifying the next frontier of innovation policy challenges and opportunities across life sciences, IP, and emerging technology sectors.
Developing a Pharmacovigilance Culture
An analysis of how countries can build robust pharmacovigilance systems to improve medicine safety monitoring and reporting across health systems.
Keeping Medicines Safe
Foundational study on medicine safety frameworks, examining how regulatory systems can be strengthened to protect patients while supporting innovation.